Severity of cardiovascular disease in postmenopausal women: Associations with common estrogen receptor α polymorphic variants

European Journal of Endocrinology

Volumn 156, Issue 4, 2007, Pages 489-496

  Alevizaki, Mani ^a   Saltiki, K ^a   Cimponeriu, A ^a   Kanakakis, I ^a   Xita, N ^b   Alevizaki, C C ^a   Georgiou, I ^b   Sarika, H L ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTROGEN ACTIVITY; FEMALE; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALLELES; BIRTH RATE; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; INSULIN; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 34247636067     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-06-0685     Document Type: Article

References (57)

1. Yamada Y, Izawa H, Ichihara S, Takatsu. F, Ishihara H, Hirayama H, Sone T, Tanaka M & Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. New England Journal of Medicine 2002 347 1916-1923.
2. Barrett-Connor E. Clinical review 162: cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. Journal of Clinical Endocrinology and Metabolism 2003 88 4031-4042.
3. Isles CG, Hole DJ, Hawthorne VM & Lever AF. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 1992 339 702-706.
4. Gordon T, Kannel WB, Hjortland MC & McNamara PM. Menopause and coronary heart disease. The Framingham study. Annals of Internal Medicine 1978 89 157-161.
5. Barrett-Connor E & Bush TL. Estrogen and coronary heart disease in women. JAMA 1991 265 1861-1867.
6. Mendelsohn ME & Karas RH. The protective effects of estrogen on the cardiovascular system. New England Journal of Medicine 1999 340 1801-1811.
7. Sudhir K & Komesaroff PA. Cardiovascular actions of estrogens in men. Journal of Clinical Endocrinology and Metabolism 1999 84 3411-3415.
8. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME & Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Reviews 2006 27 575-605.
9. Gruber CJ, Tschugguel W, Schneeberger C & Huber JC. Production and actions of estrogens. New England Journal of Medicine 2002 346 340-352.
10. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M & Golden SH. Atherosclerosis risk in communities study. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. Journal of Clinical Endocrinology and Metabolism 2005 90 1202-1209.
11. Deroo Bj & Korach KS. Estrogen receptors and human disease. Journal of Clinical Investigation 2006 116 561-570.
12. Koehler KF, Helguero LA, Haldosen LA, Warner M & Gustafsson JA. Reflections on the discovery and significance of estrogen receptor beta. Endocrine Reviews 2005 26 465-478.
13. Venkov CD, Rankin AB & Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996 94 727-733.
14. Losordo DW, Kearney M, Kim EA, Jekanowski J & Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994 89 1501-1510.
15. Nakamura Y, Suzuki T Mild Y, Tazawa C, Senzaki K, Moriya T, Saito H, Ishibashi T, Takahashi S, Yamada S & Sasano H. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens. Molecular and Cellular Endocrinology 2004 219 17-26.
16. Karas RH, Patterson BL & Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994 89 1943-1950.
17. Liu PY, Christian RC, Ruan M, Miller VM & Fitzpatrick LA. Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. Journal of Clinical Endocrinology and Metabolism 2005 90 1041-1046.
18. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS & Rubanyi GM. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997 96 3774-3777.
19. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE & Levy D. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 2003 290 2263-2270.
20. Schuit SC, Oei HH, Witteman JC, Geurts van Kessel CH, van Meurs JB, Nijhuis RL, van Leeuwen JP, de Jong FH, Zillikens MC, Holman A, Pols HA & Uitterlinden AG. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 2004 291 2969-2977.
21. Koch W. Hoppmann P, Pfeufer A, Mueller JC, Schomig A & Kastrati A. No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation 2005 112 2138-2242.
22. Rokach A, Pollak A, Rosen L, Friedlander Y, Blumenfeld A, Reznik L & Dresner-Pollak R. Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. Journal of Clinical Endocrinology and Metabolism 2005 90 6556-6560.
23. Lu H, Higashikata T, Inazu. A, Nohara A, Yu W Shimizu M & Mabuchi H. Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hyperchotesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 817-823.
24. Ferrero V, Ribichini F, Matullo G, Guarrera S, Carturan S, Vado A, Vassanelli C, Piazza A, Uslenghi E & Wijns W, Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 2223-2228.
25. Shearman AM, Cooper JA, Kotwinski PJ, Miller GJ, Humphries SE, Ardlie KG, Jordan B, Irenze K, Lunetta KL, Schuit SC, Uitterlinden AG, Pots HA, Demissie S, Cupples LA, Mendelsohn ME, Levy D & Housman DE. Estrogen receptor alpha gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circulation Research 2006 98 590-592.
26. Shearman AM, Cooper JA, Kotwinski PJ, Humphries SE, Mendelsohn ME, Housman DE & Miller GJ. Estrogen receptor alpha gene variation and the risk of stroke. Stroke 2005 36 2281-2282.
27. Pollak A, Rokach A, Blumenfeld A, Rosen LJ, Resnik L & Dresner Pollak R. Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. European Heart Journal 2004 25 240-245.
28. Petrovic D & Peterlin B. Estrogen receptor dinucleotide (TA) polymorphism does not predict premature myocardial infarction in Caucasian women. Cardiology 2003 99 163-165.
29. Evangelopoulos D, Alevizaki M, Lekakis J, Cimponeriu A, Papamichael C, Kominakis A, Kalofoutis A & Moutsatsou P. Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status. Clinica Chimica Acta 2003 331 37-44.
30. Yaich L, Dupont WD, Cavener DR & Parl FF. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Research 1992 52 77-83.
31. Saltiki K, Doukas C, Kanakakis J, Anastasiou E, Mantzou E & Alevizaki M. Severity of cardiovascular disease in women: relation with exposure to endogenous estrogen. Maturitas 2006 55 51-57.
32. Lehtimaki T, Laaksonen R, Mattila KM, Janatuinen T, Vesalainen R, Nuutila P, Laakso J, Jaakkola O, Koivula T & Knuuti J. Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men. European Journal of Clinical Investigation 2002 32 400-404.
33. Lehtimaki T, Kunnas TA, Mattila M Perola M, Penttila A, Koivula T & Karhunen PJ. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. Journal of Molecular Medicine 2002 80 176-180.
34. Mansur Ade P, Nogueira CC, Strunz CM, Aldrighi JM & Ramires JA. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Archives of Medical Research 2005 36 511-517.
35. Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K & Ikeda Y. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 3006-3012.
36. Part FF, Cavener DR & Dupont WD. Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Research and Treatment 1989 14 57-64.
37. Hill SM, Fuqua SA, Chamness GC, Greene GL & McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Research 1989 49 145-148.
38. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K & Borresen AL. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Human Genetics 1994 94 665-670.
39. Cai Q, Shu XO, lin F, Dai Q, Wen W Cheng JR, Gao YT & Zheng W. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer study. Cancer Epidemiology, Biomarkers and Prevention 2003 12 853-859.
40. Weiderpass E, Persson I, Methus H, Wedren S, Kindmark A & Baron JA. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000 21 623-627.
41. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE & Uitterlinden AG. GENOMOS study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 2004 292 2105-2114.
42. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M & Orimo, H. Association of bone mineral density with polymorphism of the estrogen receptor gene. Journal of Bone and Mineral Research 1996 11 306-311.
43. Deng HW Li J, Li JL, Dowd R, Davies KM, Johnson M, Gong G, Deng H & Recker RR. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. Journal of Clinical Endocrinology and Metabolism 2000 85 2748-2751.
44. Stavrou I, Zois C, Ioannidis JP & Tsatsoulis A. Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche. Human Reproduction 2002 17 1101-1105.
45. Weel AE, Uitterlinden AG, Westendorp IC, Burger H, Schutt SC, Hofman A, Helmerhorst TJ, van Leeuwen JP & Pots HA. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. Journal of Clinical Endocrinology and Metabolism 1999 84 3146-3150.
46. Luisi S, Galleri L, Marini F, Ambrosini G, Brandi ML & Petraglia R Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertility and Sterility 2006 85 746-764.
47. Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S, Cupples LA, Larson MG, Vasan RS, D'Agostino RB, Karas RH, Mendelsohn ME, Housman DE & Levy D. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham heart study. Journal of Hypertension 2005 23 2193-2200.
48. Kikuchi T, Hashimoto N, Kawasaki T & Uchiyama M. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatrica 2000 89 42-45.
49. Shearman AM, Demissie S, Cupples LA, Peter I, Schmid CH, Ordovas JM, Mendelsohn ME & Housman DE. Tobacco smoking, estrogen receptor alpha gene variation and small low density lipoprotein level. Human Molecular Genetics 2005 14 2405-2413.
50. Lo JC, Zhao X, Scuteri A, Brockwell S & Sowers MR. The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife. American Journal of Medicine 2006 119 S69-S78.
51. Georgiou I, Konstantelli M, Syrrou M, Messinis EE & Lolis DE. Oestrogen receptor gene polymorphisms and ovarian stimulation for in vitro fertilization. Human Reproduction 1997 12 1430-1433.
52. Gotoda T, Kinoshita M, Ishibashi S, Inaba T, Harada K, Shimada M, Osuga J, Teramoto T, Yazaki Y & Yamada N. Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1376-1381.
53. O'Neill JP, Rogan PK, Cariello N & Nicklas JA. Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. Mutation Research 1998 411 179-214.
54. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA & Bleecker ER. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. New England Journal of Medicine 2002 346 967-974.
55. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Meyers DA & Bleecker ER. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002 105 1879-1882.
56. Becherini L, Gennari L, Masi L, Mansani R, Massart F, Morelli A, Falchetti A, Gonnelli S, Fiorelli G, Tanini A & Brandt ML. Evidence of a linkage disequilibriurn between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Human Molecular Genetics 2000 9 2043-2050.
57. Alevizaki M, Cimponeriu A, Garofallaki M, Sarika. H-L, Alevizaki CC, Papamichael C, Philippou G, Anastasiou E, Lekakis J & Mavrikakis M. The androgen receptor CAG polymorphism is associated with the severity of coronary artery disease in men. Clinical Endocrinology 2003 59 749-755.